Markp Lythgoe News Today

National Cancer Research Institute is closing just when we need it most The UK’s National Cancer Research Institute (NCRI) announced unexpectedly in June 2023 that it will be permanently “winding down” activities because of ongoing uncertainties in the wider economic and research environment.12 The failure of the UK’s public research funders to ensure the sustainability and continuity of the NCRI has drawn widespread condemnation from patients, doctors, and other key stakeholders.34 This...

Investegate announcements from 4d Pharma PLC, MRx0518 SITC 2022 poster presentations

New oncology therapies generally are approved more quickly in the United States than in Europe.

TUESDAY, June 14, 2022 (HealthDay News) -- New oncology therapies generally are approved more quickly in the United States than in Europe, according to a study published online June 10 in JAMA Network Open. Mark P. Lythgoe, M.B.B.S., from Imperial College London, and colleagues analyzed differences in approval timings and review speed between new cancer

FDA received licensing applications sooner and had shorter review times, compared to the European Medicines Agency.